Inhibikase Therapeutics shares owned by Synergy Financial Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Synergy Financial Management
from 13F filings
Historical chart of Synergy Financial Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Synergy Financial Management consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Inhibikase Therapeutics by Synergy Financial Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $65 | 50 | 1.30 |
More positions owned by Synergy Financial Management
View all positions for Synergy Financial Management